List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Entrectinib Capsules

Solid Tumors

Generic Name: entrectinib. It is used to treat non-small cell lung cancer (NSCLC).

Rozlytrek (entrectinib) is a medication used for the treatment of NTRK-positive solid tumors, and ROS1-positive metastatic non-small cell lung cancer (NSCLC).

Facts about entrectinib capsules

Disease Indications-Solid Tumor
Manufacturer-Genentech, Inc
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Entrectinib Capsules” based on the information you provide.

EPKINLY (epcoritamab-bysp) injection

Lymphoma

EPKINLY (epcoritamab-bysp) injection, for subcutaneous use Initial U.S. Approval: 2023

EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma that has come back or that did not respond to previous treatment after receiving 2 or more treatments. EPKINLY is approved based on patient response data.

Brand Name:	EPKINLY
Generic Name:	epcoritamab-bysp
Strength:	• Injection: 4 mg/0.8 mL in a single-dose vial. Dilute prior to use. • Injection: 48 mg/0.8 mL in a single-dose vial.
Manufacturer:	Genmab US, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “EPKINLY (epcoritamab-bysp) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for EPKINLY (epcoritamab-bysp) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

EPKINLY (epcoritamab-bysp) injection

Lymphoma

Brand Name: EPKINLY Generic Name: (epcoritamab-bysp). EPKINLY (epcoritamab-bysp) is used to treat lymphoma.

Epcoritamab-bysp is approved to treat adults with: Diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma. Follicular lymphoma.

Brand Name:	EPKINLY
Generic Name:	epcoritamab-bysp
Strength:	• Injection: 4 mg/0.8 mL in a single-dose vial. Dilute prior to use. • Injection: 48 mg/0.8 mL in a single-dose vial.
Manufacturer:	Genmab US, Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “EPKINLY (epcoritamab-bysp)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for EPKINLY (epcoritamab-bysp) cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

ERLEADA (apalutamide) tablets

Solid Tumors, Prostate

ERLEADA (apalutamide) tablets

ERLEADA is a prescription medicine used to treat two types of prostate cancer: Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone.

Brand Name:	ERLEADA
Generic Name:	apalutamide
Strength:	• Tablets: 240 mg, 60 mg
Manufacturer:	Janssen Products, LP.
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ERLEADA (apalutamide) tablets” based on the information you provide.

Erlotinib Tablets

Lung Cancer

erlotinib tablets
oral Initial U.S. Approval: 2004

Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.

Facts about erlotinib tablets

Approval Date: 2004
Proprietary Name: On Request
Active Ingredient(s): erlotinib tablets
Dosage Forms And Strengths: Tablets: 25 mg, 100 mg and 150 mg
Company:
Current indications: non-small cell lung cancer (NSCLC)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “erlotinib tablets” based on the information you provide.

Estramustine Phosphate Sodium Capsules

Prostate

estramustine phosphate sodium capsules

estramustine phosphate sodium capsules are indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate

Facts about estramustine phosphate sodium capsules

Proprietary Name: On Request
Active Ingredient(s): estramustine phosphate sodium capsules
Dosage Forms And Strengths: White opaque capsules, each containing estramustine phosphate sodium as the disodium salt monohydrate equivalent to 140 mg estramustine phosphate—bottle of 100 (NDC 0013-0132-02).
Company: pfizer
Current indications: prostate
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import estramustine phosphate sodium capsules” based on the information you provide.

Everolimus Tablets

Breast Cancer, Gastrointestinal, Kidney, Lung Cancer

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Fam-trastuzumab Injection

Breast Cancer

Fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019

Generic Name – Fam-Trastuzumab
Medicine Type – Injection / Intravenous
Manufacturer Name – Daiichi-Sankyo, Inc
Approval Year – 2022
Approved by -Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import fam-trastuzumab Injection” based on the information you provide.

Fedratinib Capsules

Bone Cancer

fedratinib capsules
for oral use Initial U.S. Approval: 2019

Inrebic (fedratinib) is a medication used for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.

Facts about fedratinib capsules

Disease Indications-Myelofibrosis
Manufacturer-Impact Biomedicines, Inc.
Usage-Oral
Medicine Approved By- European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Fedratinib Capsuless” based on the information you provide.

FILSUVEZ (birch triterpenes)

Skin

Brand Name: FILSUVEZ Generic Name: (birch triterpenes)
FILSUVEZ (birch triterpenes) is used to treat wounds associated with dystrophic and junctional epidermolysis bullosa.

Filsuvez is a medicine that is used in adults and children aged 6 months or older with epidermolysis bullosa (EB). EB is an inherited disease of the skin that makes the skin very fragile and causes severe blistering and scarring.

Brand Name:	FILSUVEZ
Generic Name:	birch triterpenes
Strength:	Topical gel: 10% birch triterpenes w/w supplied in 25 mL sterile tubes
Manufacturer:	Amryt Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “FILSUVEZ (birch triterpenes)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for FILSUVEZ (birch triterpenes) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

Generic Name: entrectinib. It is used to treat non-small cell lung cancer (NSCLC).

Facts about entrectinib capsules

Access the best support services globally

EPKINLY (epcoritamab-bysp) injection, for subcutaneous use Initial U.S. Approval: 2023

Brand Name: EPKINLY Generic Name: (epcoritamab-bysp). EPKINLY (epcoritamab-bysp) is used to treat lymphoma.

ERLEADA (apalutamide) tablets

Access the best support services globally

erlotinib tablets oral Initial U.S. Approval: 2004

Facts about erlotinib tablets

Access the best support services globally

estramustine phosphate sodium capsules

Facts about estramustine phosphate sodium capsules

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

Fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019

Access the best support services globally

fedratinib capsules for oral use Initial U.S. Approval: 2019

Facts about fedratinib capsules

Access the best support services globally

Brand Name: FILSUVEZ Generic Name: (birch triterpenes) FILSUVEZ (birch triterpenes) is used to treat wounds associated with dystrophic and junctional epidermolysis bullosa.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

erlotinib tablets
oral Initial U.S. Approval: 2004

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

fedratinib capsules
for oral use Initial U.S. Approval: 2019

Brand Name: FILSUVEZ Generic Name: (birch triterpenes)
FILSUVEZ (birch triterpenes) is used to treat wounds associated with dystrophic and junctional epidermolysis bullosa.